Altek Corporation (TPE:3059)

Blueprint Medicines Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	7,967	7,196	9,099	14,028	9,086	6,103
Revenue Growth (YoY)	0.33%	-20.92%	-35.14%	54.40%	48.88%	-1.40%
Cost of Revenue	5,771	5,105	6,639	11,131	6,927	4,581
Gross Profit	2,196	2,091	2,460	2,898	2,159	1,522
Selling, General & Admin	739.7	692.94	693.63	720.72	528.99	378.69
Research & Development	1,063	1,071	1,407	1,734	1,397	1,059
Operating Expenses	1,802	1,763	2,102	2,455	1,926	1,436
Operating Income	394.06	327.81	357.98	443	232.47	85.47
Interest Expense	-52.41	-57.01	-64.12	-42.19	-25.85	-25.2
Interest & Investment Income	225.29	224.83	199.78	83.3	73.32	104.91
Currency Exchange Gain (Loss)	26.69	26.69	-0.05	119.2	14.23	21.72
Other Non Operating Income (Expenses)	86.56	86.26	99.73	60.71	64.54	45.98
EBT Excluding Unusual Items	680.19	608.58	593.33	664.03	358.71	232.88
Gain (Loss) on Sale of Investments	-10.3	-10.3	10.03	4.42	38.69	8.54
Gain (Loss) on Sale of Assets	-0.58	-0.58	0.29	0.66	-0.03	0.02
Other Unusual Items	-	-	0.05	-	-	-
Pretax Income	668.91	597.7	603.71	669.11	397.37	241.44
Income Tax Expense	194.12	176.27	193.81	181.07	117.11	79.93
Earnings From Continuing Operations	474.79	421.43	409.9	488.04	280.26	161.51
Minority Interest in Earnings	-123.19	-103.43	-58.91	-31.3	-55.53	-1.15
Net Income	351.61	318.01	350.99	456.74	224.73	160.36
Net Income to Common	351.61	318.01	350.99	456.74	224.73	160.36
Net Income Growth	1.49%	-9.40%	-23.15%	103.24%	40.15%	90.20%
Shares Outstanding (Basic)	293	277	277	273	266	266
Shares Outstanding (Diluted)	294	280	279	277	271	270
Shares Change (YoY)	5.39%	0.38%	0.63%	2.50%	0.13%	-1.65%
EPS (Basic)	1.20	1.15	1.27	1.67	0.85	0.60
EPS (Diluted)	1.19	1.13	1.26	1.65	0.83	0.59
EPS Growth	-3.94%	-10.32%	-23.64%	98.80%	40.68%	91.64%
Free Cash Flow	850.23	1,085	1,455	280.87	-603.54	223.08
Free Cash Flow Per Share	2.89	3.87	5.21	1.01	-2.23	0.82
Dividend Per Share	1.000	1.000	0.700	1.000	0.700	0.500
Dividend Growth	42.86%	42.86%	-30.00%	42.86%	40.00%	-
Gross Margin	27.57%	29.06%	27.04%	20.66%	23.76%	24.94%
Operating Margin	4.95%	4.56%	3.93%	3.16%	2.56%	1.40%
Profit Margin	4.41%	4.42%	3.86%	3.26%	2.47%	2.63%
Free Cash Flow Margin	10.67%	15.07%	15.99%	2.00%	-6.64%	3.65%
EBITDA	596.91	523.36	791.6	825.69	542.54	347.33
EBITDA Margin	7.49%	7.27%	8.70%	5.89%	5.97%	5.69%
D&A For EBITDA	202.86	195.55	433.61	382.69	310.07	261.86
EBIT	394.06	327.81	357.98	443	232.47	85.47
EBIT Margin	4.95%	4.56%	3.93%	3.16%	2.56%	1.40%
Effective Tax Rate	29.02%	29.49%	32.10%	27.06%	29.47%	33.11%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.